Medicare Enrolled

Dr. Clark Rogers, M.D.

Radiation Oncology · Orlando, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
601 E ROLLINS ST, Orlando, FL 32803
4072002355
In practice since 2009 (16 years)
NPI: 1649408105 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rogers from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rogers? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rogers

Dr. Clark Rogers is a radiation oncology specialist in Orlando, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Rogers performed 7,443 Medicare services across 2,804 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rogers received a total of $989 from 8 pharmaceutical and/or device companies across 30 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rogers is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 25% volume in FL $989 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,443
Medicare services
Top 25% in FL for radiation oncology
2,804
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~465 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
MRI contrast dye injection (gadoterate) 4,613 $0 $2
Chest X-ray, 1 view 644 $7 $27
Screening mammography 623 $113 $307
3D screening mammography (tomosynthesis) 622 $49 $131
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 232 $40 $137
Diagnostic mammography of both breasts 143 $101 $415
Limited ultrasound scan of 1 breast 127 $61 $234
Diagnostic mammography of 1 breast 105 $84 $328
CT scan of abdomen and pelvis with contrast 72 $62 $263
X-ray of abdomen, 1 view 58 $7 $27
Ct scan of abdomen and pelvis without contrast 46 $61 $251
Complete ultrasound scan of 1 breast 43 $112 $378
Chest X-ray, 2 views 35 $8 $32
Mri scan of both breasts 29 $272 $992
CT scan of chest, without contrast 26 $38 $155
Biopsy of breast and placement of locating device using ultrasound, first growth 14 $354 $1,670
Ct scan of chest with contrast 11 $39 $168
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$989
Total received (2018-2024)
Avg $141/year across 7 years
Top 26% in FL for radiation oncology
8
Companies
30
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$989 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$28
2023
$232
2022
$278
2021
$249
2020
$33
2019
$140
2018
$28

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HOLOGIC INC
$320
Siemens Medical Solutions USA, Inc.
$276
Bard Peripheral Vascular, Inc.
$130
Merit Medical Systems Inc
$116
LEICA MICROSYSTEMS INC.
$62
Hologic Sales and Service, LLC
$43
Terumo Medical Corporation
$28
Elucent Medical
$14
Top 3 companies account for 73.4% of total payments
Associated products mentioned in payments ›
3DIMENSIONS · 3DQUORUM · AngioSeal · BIOPSY SITE IDENTIFIERS · BREVERA BREAST BIOPSY SYSTEM · HydroMARK Breast Biopsy Site Marker · Mammomat Revelation · QUANTRA · S2000 HELX with Touch Control · Savi SCOUT
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $13 per 100 Medicare services performed
Looking for a radiation oncology specialist in Orlando?
Compare radiation oncologists in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
245
Per 100K population
17.0
County median income
$77,011
Nearest hospital
ADVENTHEALTH ORLANDO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rogers is a mixed practice specialist, with above-average Medicare volume (top 25% in FL), with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rogers experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. Rogers performed 4,613 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rogers receive payments from pharmaceutical companies?
Yes. Dr. Rogers received a total of $989 from 8 companies across 30 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rogers's costs compare to other radiation oncologists in Orlando?
Dr. Rogers's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rogers) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →